Suchergebnisse - "Omalizumab"

PubPharm (8)

1

Latest Breakthroughs in the Treatment of Atopic Dermatitis

Erschienen: [Erscheinungsort nicht ermittelbar], IntechOpen, 2024

von Skayem, C. | Anh Duong, T.

2

Patient group input submissions : Omalizumab (Xolair) for asthma, severe persistent

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2017 Sep

CADTH common drug review

3

Pharmacoeconomic review report : Omalizumab (Xolair)

Erschienen: Ottawa (ON), CADTH, September 2017

CADTH common drug review

4

Omalizumab (Xolair)

Erschienen: Ottawa (ON), CADTH, September 2017

Common drug review clinical review report

5

CADTH Canadian Drug Expert Committee final recommendation : indication: asthmaOmalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, May 18, 2016

CADTH common drug review

6

Omalizumab (Xolair) : treatment of adults and adolescents (12 years of age and above) with chronic idiopathic urticaria

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2015

Common drug review

7

Omalizumab versus "Usual Care": Results from a Naturalistic Longitudinal Study in Routine Care

Erschienen: Dresden, Technische Universität Dresden, Fakultät Mathematik und Naturwissenschaften, Professur für Klinische Psychologie und Psychotherapie, 2012

von Wittchen, H. | Mühlig, S. | Klotsche, J. | +3

8

Allergisches Asthma : 20 Xolair®-Kasuistiken

Erschienen: Stuttgart, Georg Thieme Verlag, 2007

von Wahn, U. | Kardos, P.

1
[1]